Vikram Jog - 21 Feb 2023 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
23 Feb 2023, 19:44:48 UTC
Prior SEC filing
20 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Vikram Jog

Key filing fact

Vikram Jog filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 23 Feb 2023.

Key facts

  • This page summarizes Vikram Jog's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
  • 11 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 23 Feb 2023, 19:44.

Change

  • Previous filing in this sequence was filed on 20 Jan 2023.
  • Current net transaction value: -$58,275.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LAB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+50,000
Change %
+29%
Price
$0.000000
Shares after
221,904
Date
21 Feb 2023
Ownership
Direct
LAB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+16,666
Change %
+7.5%
Price
$0.000000
Shares after
238,570
Date
21 Feb 2023
Ownership
Direct
LAB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+2,238
Change %
+0.94%
Price
$0.000000
Shares after
240,808
Date
21 Feb 2023
Ownership
Direct
LAB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+2,391
Change %
+0.99%
Price
$0.000000
Shares after
243,199
Date
21 Feb 2023
Ownership
Direct
LAB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+3,130
Change %
+1.3%
Price
$0.000000
Shares after
246,329
Date
21 Feb 2023
Ownership
Direct
LAB transaction

Common Stock

Tax liability

Transaction value
$58,275
Shares
-28,707
Change %
-12%
Price
$2.03
Shares after
217,622
Date
21 Feb 2023
Ownership
Direct
LAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
52,061
Date
21 Feb 2023
Ownership
See Footnote
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LAB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-50,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
21 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,000
Exercise price
Footnotes
F2, F3
LAB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-16,666
Change %
-8.3%
Price
$0.000000
Shares after
183,334
Date
21 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16,666
Exercise price
Footnotes
F2, F4
LAB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-2,238
Change %
-100%
Price
$0.000000*
Shares after
0
Date
21 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,238
Exercise price
Footnotes
F2, F5
LAB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-2,391
Change %
-20%
Price
$0.000000
Shares after
9,563
Date
21 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,391
Exercise price
Footnotes
F2, F6
LAB transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
-3,130
Change %
-10%
Price
$0.000000
Shares after
28,176
Date
21 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,130
Exercise price
Footnotes
F2, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Shares held indirectly by the Vikram and Pratima Family Trust U/A dated June 23, 2009.

Footnote F2

Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

Footnote F3

The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause."

Footnote F4

On December 20, 2022, the Reporting Person was granted 200,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.

Footnote F5

On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Footnote F6

On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

Footnote F7

On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .